Related Experiment Videos
The effect of 5-fluorouracil on rat adrenal function
Medical Oncology and Tumor Pharmacotherapy
|January 1, 1986
Summary
High-dose 5-fluorouracil (5-FU) causes adrenal hyperplasia and impairs corticosteroidogenesis in rats. Lower doses of 5-FU and actinomycin D induce less adrenal hyperplasia but elevate corticosterone.
Area of Science:
- Endocrinology
- Pharmacology
- Toxicology
Background:
- 5-fluorouracil (5-FU) is a chemotherapy agent.
- Adrenal gland function and size can be affected by various systemic insults.
- Corticosteroidogenesis is a critical endocrine function regulated by the hypothalamic-pituitary-adrenal (HPA) axis.
Purpose of the Study:
- To investigate the impact of 5-fluorouracil (5-FU) on corticosteroidogenesis and adrenal gland size in a rat model.
- To determine if these effects are dose-dependent.
- To compare the effects of 5-FU with actinomycin D, another cytotoxic agent.
Main Methods:
- Rats were administered daily intraperitoneal injections of 5-FU (12.5 mg/kg or 25 mg/kg), normal saline, or actinomycin D (0.02 mg/kg) for 10 days.
- Adrenal gland size was assessed.
- Corticosterone and ACTH levels were measured to evaluate corticosteroidogenesis.
Main Results:
- High-dose 5-FU (25 mg/kg) resulted in significant adrenal hyperplasia.
- High-dose 5-FU was associated with impaired corticosteroidogenesis, indicated by lower corticosterone and higher ACTH levels.
- Low-dose 5-FU (12.5 mg/kg) and actinomycin D induced less adrenal hyperplasia compared to high-dose 5-FU.
- Low-dose 5-FU and actinomycin D treatments led to elevated corticosterone levels.
Conclusions:
- 5-fluorouracil exhibits a dose-dependent effect on adrenal function in rats.
- High-dose 5-FU induces adrenal hyperplasia and suppresses corticosteroidogenesis.
- Low-dose 5-FU and actinomycin D cause milder adrenal changes but can elevate corticosterone levels, suggesting complex interactions within the HPA axis.